2021
DOI: 10.5415/apallergy.2021.11.e25
|View full text |Cite
|
Sign up to set email alerts
|

Suppressive effect of dexamethasone on murine Th9 cell-mediated nasal eosinophilic inflammation

Abstract: Background Th9 cells have been implicated in the development of allergic inflammation, though its contribution to allergic rhinitis and the effect of steroid on Th9 cell-mediated nasal responses are unclear. Objective In this study, allergen-induced nasal inflammatory responses and their steroid responsiveness were investigated in ovalbumin (OVA)-specific Th9 cell-transferred mice. Methods BALB/c mice were transferred with in vi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 11 publications
0
3
0
Order By: Relevance
“…[1][2][3] Inflammatory responses in the nasal mucosa are typical features of AR and are frequently accompanied by the infiltration of immune cells, including T cells, eosinophils, and basophils. 4,5 Previous studies have confirmed that the microbiome directly affects inflammatory responses in allergic diseases such as AR and asthma. [6][7][8] Therefore, the study of the composition of the microbiota is of great importance for understanding the pathogenesis of AR.…”
Section: Introductionmentioning
confidence: 96%
“…[1][2][3] Inflammatory responses in the nasal mucosa are typical features of AR and are frequently accompanied by the infiltration of immune cells, including T cells, eosinophils, and basophils. 4,5 Previous studies have confirmed that the microbiome directly affects inflammatory responses in allergic diseases such as AR and asthma. [6][7][8] Therefore, the study of the composition of the microbiota is of great importance for understanding the pathogenesis of AR.…”
Section: Introductionmentioning
confidence: 96%
“…At the start of culturing, pre-washed Dynabeads Mouse T-Activator CD3/CD28 (2 μL/10 5 cells, Thermo Fisher Scientific) and recombinant IL-2 (10 U/mL, PeproTech, Inc., Cranbury, NJ, USA) were added. To promote differentiation into each subset, cells were cultured for 7 to 10 days in the presence of appropriate cytokines and anti-cytokine antibodies as follows[7][8][9][10][11][12]. Th1: 10 U/mL IL-PeproTech) and 10 µg/mL anti-IL-4 monoclonal antibody (mAb) (BD Biosciences, San Jose, CA, USA), Th2: 10 U/mL IL-4 (PeproTech) and 10 μg/mL anti-IFN-γ mAb (R4-6A2, eBioscience, San Diego, CA, USA), Th9: 10 U/mL IL-4, 5 ng/mL TGF-β (BioLegend, San Diego, CA, USA), and 10 μg/mL anti-IFN-γ mAb, Th17: 10 ng/mL IL-1β (Peprotech), 20 ng/mL IL-6 (Peprotech), 1 ng/mL TGF-β, 10 ng/mL IL-23 (R & D Systems, Minneapolis, MN, USA), 40 μg/mL anti-IL-4 mAb, and 40 μg/mL anti-IFN-γ mAb, Treg: 5 ng/mL TGF-β, 2 nM trans-Retinoic Acid (Calbiochem, San Diego, CA, USA), 40 μg/mL anti-IL-4 mAb, and 40 μg/mL anti-IFN-γ mAb.…”
mentioning
confidence: 99%
“…Essentially the same responses were observed in both the #75 and #97 lines, though the stimulation-induced upregulation of EGFP fluorescence was hardly detectable by microscopic analysis.The difference in the reporter activity of established NFAT reporter mouse lines was further evaluated in differentiated helper T (Th)1, Th2, Th9, Th17, and regulatory T (Treg) cells. Th1 cells differentiated by our procedure preferentially express IFN-γ and CXCR3, Th2 express IL-4, IL-5, IL-13, and CCR4, Th9 express IL-9, Th17 express IL-17A, IL-22, and RORγt, and Treg express TGF-β1, IL-10, CTLA-4, CD25, and FoxP3 as described previously[7][8][9][10][11][12]. As shown in Fig.3, The expression of EGFP was upregulated by CD3/CD28 and PMA + IOM in all subsets.…”
mentioning
confidence: 99%